TechnipFMC Q3 2026: Strong Earnings, but Valuation Remains Stretched

What happened

TechnipFMC reported Q3 2026 revenue of $2.90 billion, up 4.8% sequentially and 9.4% year-over-year, with net income of $418.4 million, a 35.3% sequential increase and 35.1% year-over-year increase from $309.7 million in Q3 2025. These results confirm continued momentum in subsea activity and margin expansion, with net margin improving from 11.7% to 14.4% year-over-year, consistent with the company's strong backlog execution and iEPCI™ traction highlighted in the recent 10-K and 10-Q. However, the stock already trades at a premium valuation of ~20x earnings and ~14x EV/EBITDA, about 124% above a conservative DCF intrinsic value estimate of $21 per share, as noted in the previous DeepValue report. While the operational results are solid and support the quality-of-earnings story, they do not resolve the core issue of limited margin of safety at current prices, especially given the cyclical and project-risk nature of the business. Therefore, the WAIT stance remains appropriate: investors should monitor for any pullback or evidence of structural margin sustainability before considering a more constructive position.

Implication

TechnipFMC's Q3 2026 beat is consistent with its multi-year backlog and improving margins, but at ~20x earnings and a ~124% premium to DCF, the market is pricing in sustained high performance. Investors should remain patient, focusing on future order intake, margin durability, and any valuation reset before adding exposure. The risk of cyclical downturn or project execution issues in a long-cycle business argues against chasing the stock at current levels. Continue to watch for signs of backlog quality deterioration or policy shifts that could alter the offshore spending trajectory.

Thesis delta

No material change to the investment thesis: the WAIT stance remains unchanged because Q3 2026 results confirm operational strength but do not address the valuation overhang. The earnings beat may further boost sentiment and share price, potentially increasing the already elevated valuation, but it does not improve the fundamental risk/reward for new capital. Thus, the thesis remains that TechnipFMC is a high-quality cyclical trading at full value.